OraSure Technologies (NASDAQ:OSUR) Cut to “Hold” at StockNews.com

StockNews.com downgraded shares of OraSure Technologies (NASDAQ:OSUR) from a buy rating to a hold rating in a research note issued to investors on Saturday.

OraSure Technologies Price Performance

NASDAQ:OSUR opened at $3.99 on Friday. The firm’s 50 day simple moving average is $3.80 and its 200 day simple moving average is $4.02. OraSure Technologies has a one year low of $3.52 and a one year high of $8.04. The company has a market cap of $297.63 million, a PE ratio of 26.60 and a beta of 0.05.

Institutional Investors Weigh In On OraSure Technologies

Hedge funds have recently added to or reduced their stakes in the business. Tower Research Capital LLC TRC boosted its position in OraSure Technologies by 202.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 7,821 shares of the medical instruments supplier’s stock worth $28,000 after buying an additional 5,234 shares during the period. Causeway Capital Management LLC acquired a new position in shares of OraSure Technologies in the 4th quarter worth approximately $36,000. Raymond James Financial Inc. acquired a new position in shares of OraSure Technologies in the 4th quarter worth approximately $37,000. Atom Investors LP acquired a new position in shares of OraSure Technologies in the 3rd quarter worth approximately $49,000. Finally, Boothbay Fund Management LLC acquired a new position in shares of OraSure Technologies in the 4th quarter worth approximately $42,000. 93.50% of the stock is currently owned by institutional investors and hedge funds.

OraSure Technologies Company Profile

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.